Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
The Associated Press
July 27, 2025, 9:15 AM
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn’t pay to fix the problem and she sank back into a dangerous darkness.
She worried for her life, asking herself: “Why am I putting myself through this?”
Seeger’s predicament highlights a growing problem for hundreds of people with experimental neural implants, including ]those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there’s no guarantee that their devices will be maintained — particularly after they finish participating in clinical trials — and no mechanism requiring companies or insurers to do so.
{snip}
The Associated Press
July 27, 2025, 9:15 AM
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn’t pay to fix the problem and she sank back into a dangerous darkness.
She worried for her life, asking herself: “Why am I putting myself through this?”
Seeger’s predicament highlights a growing problem for hundreds of people with experimental neural implants, including ]those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there’s no guarantee that their devices will be maintained — particularly after they finish participating in clinical trials — and no mechanism requiring companies or insurers to do so.
{snip}